Pioneer Biotech Secures Exclusive ERAD Plus® Distribution Rights in Asia, Offering New Hope for Pancreatic Beta Cell Regeneration

Source: PIONEER BIOTECH CO.,LTD ( Healthcare+ Expo- booth no.: I1129A)

Pioneer Biotech Secures Exclusive ERAD Plus® Distribution Rights in Asia, Offering New Hope for Pancreatic Beta Cell Regeneration**

ERAD Complements a Missing Link in Current Pharmaceutical Blood Sugar Management

**Taipei, August 26, 2024** — Pioneer Biotech Co., Ltd. today announced that it has secured the exclusive rights from U.S.-based Bio Pleo to distribute its newly developed natural health product, ERAD Plus® tablets, across Asia. The company received Taiwan’s Ministry of Health and Welfare's import approval for the product in June of this year. ERAD Plus® is designed to improve the health of pancreatic beta cells in diabetic patients by enhancing the physiological process known as Endoplasmic Reticulum-Associated Degradation (ERAD). This process helps correct misfolded proinsulin, preventing the accumulation of errors that lead to endoplasmic reticulum stress. ERAD Plus® provides a unique opportunity for protecting and regenerating pancreatic beta cells, slowing the progression of diabetes and working synergistically with existing glucose-lowering medications.

**Innovative Mechanism to Protect Pancreatic Beta Cells**

The U.S.-based ERAD Plus® research team, after over a decade of study, successfully identified several natural plant extracts that accelerate the ERAD process. These extracts clear misfolded proinsulin from pancreatic beta cells, reducing apoptosis. The innovative mechanism of this product aims to alleviate the overworked state of pancreatic beta cells, offering them a chance to regenerate and improve both their quantity and functionality.

**Clinically Proven to Significantly Improve Blood Sugar Control**

In a three-month clinical trial involving 78 diabetic patients, ERAD Plus® demonstrated significant efficacy. The results showed that, when used in conjunction with traditional glucose-lowering drugs, ERAD Plus® significantly reduced HbA1c levels within six weeks. Some patients even achieved healthy blood sugar levels and were able to reduce their medication dosage.

**Natural Ingredients, Safe and Reliable**

ERAD Plus® tablets are made from natural herbal extracts and are manufactured in a GMP-certified pharmaceutical facility in the United States. The product has undergone rigorous quality testing in FDA-approved third-party laboratories, ensuring its safety and efficacy.

**Looking Ahead**

Pioneer Biotech hopes that the launch of ERAD Plus® will provide a more comprehensive health management solution for diabetic patients worldwide. The company is committed to bringing this innovative product to a broader market and actively seeks collaboration opportunities with health experts to help more patients effectively manage their condition and improve their quality of life.

**About Pioneer Biotech Co., Ltd.**

Founded in 2023 and based in Taipei, Taiwan, Pioneer Biotech Co., Ltd. is a company with team members who have backgrounds as biomedical professors in U.S. medical schools and expertise from National Taiwan University in biotech management. The company focuses on preventive medicine and health management, emphasizing innovation and scientific evidence. In late 2023, Pioneer Biotech introduced its products to the Asian market and plans to launch a health platform in 2024, offering professional consultation and premium services. Pioneer Biotech is dedicated to helping clients achieve their health management goals and invites more people to join this new journey toward health.

**Media Contact:**

Pioneer Biotech Co., Ltd.

Contact: [Cindy Huang]

Phone: [+886-2-8286-6876]

Email: [365@healer.tw]

Website: www.erad365.com